±±¾©Ê¯ÓÍ»¯¹¤Ñ§Ôº2026ÄêÑо¿ÉúÕÐÉú½ÓÊÕµ÷¼Á¹«¸æ
²é¿´: 328  |  »Ø¸´: 3
µ±Ç°Ö÷ÌâÒѾ­´æµµ¡£
±¾Ìû²úÉú 1 ¸ö ·­ÒëEPI £¬µã»÷ÕâÀï½øÐв鿴
µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû

zqxia2009

Ìú¸Ëľ³æ (ÕýʽдÊÖ)

[½»Á÷] ÓÐЩµØ·½·­Òë²»ºÃ£¬ÇëÇó°ïÖú

Figure 6 shows the cumulative percentages of patients from each of the treatment groups who had attained at least the measure of improvement in the ADCS-ADL shown on the X axis.The curves show that both patients assigned to NAMENDA/donepezil and placebo/donepezil have a wide range of responses and generally show deterioration, but that the NAMENDA/donepezil group is more likely to show a smaller decline or an improvement¡£

» ²ÂÄãϲ»¶

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

benmao_mogu

ľ³æ (ÖøÃûдÊÖ)

¡ï
zqxia2009(½ð±Ò+1, ·­ÒëEPI+1): 2010-04-19 13:37
sirljz(½ð±Ò+1):лл½»Á÷£¬ºÜ»ý¼«£¬»¶Ó­³£À´ 2010-04-19 15:50
ͼ6ÏÔʾÁËÿһ×鲡ÈËÖÎÁƵÄÀÛ»ýÒÑ´ïµ½µÄ°Ù·Ö±È±íÃ÷ÖÁÉÙÔÚADCµÄ- ADLµÄ¸ÄÉÆ¶ÔX axis.ÇúÏß±íÃ÷·ÖÅ䏸NAMENDA /¶àÄÎß߯ë×éºÍ°²Î¿¼Á/¶àÄÎß߯ëÁ½Ãû»¼ÕßÓÐ׏㷺µÄ·´Ó¦²¢ÆÕ±é±íÏÖ³ö¶ñ»¯£¬µ«¸ÃNAMENDA /¶àÄÎß߯ë×é¸ü¿ÉÄÜÕ¹ÏÖ³öÉÔ΢µÄϽµ»ò¸ÄÉÆ¡£
²»Æ´²«£¬ÔõÄÜÏíÊÜÃÀºÃÉú»î
3Â¥2010-04-19 11:12:09
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
²é¿´È«²¿ 4 ¸ö»Ø´ð

lhhe

¸ø¸öÖÐÎİ棬ºÃ¸øÄã·­¡£²ÂÓ¢ÎÄÈÝÒ×ÒýÆðÎó½â¡£
2Â¥2010-04-19 08:55:07
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

zqxia2009

Ìú¸Ëľ³æ (ÕýʽдÊÖ)

Â¥ÉϵÄÕ½ÓÑ£¬ÎÒ¿´ÁËÄãµÄ·­Òëºó£¬¸Ð¾õÒ²²»ÊÇ̫˳Áïѽ¡£ÄãÄܲ»ÄÜÔÚÕå×ÃÒ»ÏÂѽ
4Â¥2010-04-19 13:45:11
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] 290Çóµ÷¼Á +7 luoziheng 2026-04-04 7/350 2026-04-04 23:17 by lqwchd
[¿¼ÑÐ] 340Çóµ÷¼Á +4 jhx777 2026-03-29 4/200 2026-04-04 20:08 by Î޼ʵIJÝÔ­
[¿¼ÑÐ] Ò»Ö¾Ô¸»ª±±µçÁ¦´óѧ£¨±±¾©£©£¬²ÄÁÏ¿ÆÑ§Ó빤³Ìѧ˶265£¬Çóµ÷¼Á +11 yelck 2026-04-03 12/600 2026-04-04 19:52 by dongzh2009
[¿¼ÑÐ] 306Çóµ÷¼Á +3 hybÉÏÃû¹¤ 2026-04-02 3/150 2026-04-04 18:12 by ÈÈÇéɳĮ
[¿¼ÑÐ] 335Çóµ÷¼Á +7 ÉòÇåÁ§ 2026-04-03 7/350 2026-04-03 18:55 by lijunpoly
[¿¼ÑÐ] Çóµ÷¼Á²»Ìôרҵ +3 xrh030412 2026-04-01 3/150 2026-04-03 14:40 by µªÆøÆøÆø
[¿¼ÑÐ] Ò»Ö¾Ô¸ÉúÎïÓëÒ½Ò©£¬296·Ö£¬Çóµ÷¼Á +8 66¹ 2026-04-03 9/450 2026-04-03 14:22 by »¯Ñ§»¯¹¤Ë¶Ê¿ÕÐÉ
[¿¼ÑÐ] ²ÄÁÏ¿¼Ñе÷¼Á +10 Gs´óÍõ 2026-04-02 10/500 2026-04-03 09:47 by ÒÅÍüÏûʧµÄž™
[¿¼ÑÐ] Ò»Ö¾Ô¸ÏÃÃÅ´óѧ²ÄÁϹ¤³Ìר˶354ÕÒµ÷¼Á£¡£¡£¡ +8 ±´ß±µ±µ 2026-03-30 8/400 2026-04-03 09:41 by hypershenger
[¿¼ÑÐ] 366Çóµ÷¼ÁÒ»Ö¾Ô¸¶«±±´óѧ +8 ÔËÆøÀ´µÃÈôÓÐËÆÎ 2026-04-02 8/400 2026-04-02 21:39 by dongzh2009
[¿¼ÑÐ] Çóµ÷¼ÁÍÆ¼ö +3 ÄÏɽÄÏ@ 2026-04-01 3/150 2026-04-02 12:09 by xiaoranmu
[¿¼ÑÐ] 261ÇóBÇøµ÷¼Á +5 Ã÷×С¤ 2026-04-01 7/350 2026-04-02 11:17 by ×Þξξ
[¿¼ÑÐ] 377Çóµ÷¼Á +3 RASKIN 2026-04-02 3/150 2026-04-02 09:45 by zzchen2000
[¿¼ÑÐ] ¿¼Ñе÷¼Á +12 Amber00 2026-03-31 12/600 2026-04-02 09:04 by sanrepian
[¿¼ÑÐ] 08¹¤¿Æ£¬295£¬½ÓÊÜ¿çרҵµ÷¼Á +6 lmnlzy 2026-03-31 6/300 2026-04-01 11:02 by ÄæË®³Ë·ç
[¿¼ÑÐ] 335Çóµ÷¼Á +3 321* 2026-03-31 4/200 2026-04-01 00:00 by 321*
[¿¼ÑÐ] 289Çóµ÷¼Á +7 BrightLL 2026-03-29 7/350 2026-03-31 22:05 by 544594351
[¿¼ÑÐ] Ò»Ö¾Ô¸Äϲý´óѧ324Çóµ÷¼Á +6 hanamiko 2026-03-29 6/300 2026-03-31 16:35 by hypershenger
[¿¼ÑÐ] ÉúÎÑÐ337·ÖÇóµ÷¼Á +4 cgxin 2026-03-30 6/300 2026-03-31 14:18 by ¼Çʱ¾2026
[¿¼ÑÐ] Ò»Ö¾Ô¸Öк£Ñó320»¯Ñ§¹¤³ÌÓë¼¼Êõѧ˶Çóµ÷¼Á +8 ÅûÐÇºÓ 2026-03-30 8/400 2026-03-31 08:53 by lbsjt
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û